Use of non-selective beta blockers in cirrhosis: the evidence we need before closing (or not) the window

World Journal of Gastroenterology : WJG
Vincenzo La MuraFrancesco Salerno

Abstract

Non selective beta blockers (NSBBs) are used in primary and secondary prophylaxis of portal hypertension-related bleeding in patients with cirrhosis. The efficacy of NSBBs treatment is predicted by hemodynamic response in term of reduction of the hepatic venous pressure gradient (HVPG) below 12 mmHg or at least 20% of the basal value. Nevertheless a relevant number of patients who do not achieve this HVPG reduction during NSBBs therapy do not bleed during follow up; this evidence suggests an additional non-hemodynamic advantage of NSBBs treatment to modify the natural history of cirrhosis. Recent studies have questioned the efficacy and safety of NSBBs in patients with advanced stage of liver disease characterized by refractory ascites and/or spontaneous bacterial peritonitis. These studies have suggested the existence of a defined and limited period to modify the natural history of cirrhosis by NSBBs: the "window hypothesis". According with this hypothesis, patients with cirrhosis benefit from the use of NSBBs from the appearance of varices up to the development of an advanced stage of cirrhosis. Indeed, in patients with refractory ascites and/or spontaneous bacterial peritonitis the hemodynamic effects of NSBBs may expose to ...Continue Reading

References

Sep 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R W SchrierJ Rodés
Apr 2, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Juan G AbraldesJaime Bosch
Oct 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Luis Ruiz-del-ArbolVicente Arroyo
Aug 10, 2004·Gastroenterology·Carlo MerkelUNKNOWN Gruppo Triveneto per l'Ipertensione Portale
Nov 25, 2005·The New England Journal of Medicine·Roberto J GroszmannUNKNOWN Portal Hypertension Collaborative Group
Mar 18, 2006·The American Journal of Gastroenterology·Juan TurnesJaime Bosch
Feb 24, 2007·Journal of Hepatology·Christian GluudRonald L Koretz
Mar 30, 2007·Journal of Hepatology·Vicente ArroyoPere Ginès
Dec 7, 2007·Gastroenterology·Ulrich ThalheimerAndrew K Burroughs
Jun 11, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Marco SenzoloAndrew Kenneth Burroughs
Sep 3, 2009·Nature Reviews. Gastroenterology & Hepatology·Jaime BoschJuan Carlos García-Pagan
Jan 16, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Guadalupe Garcia-TsaoMassimo Pinzani
Jun 29, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Thomas SerstéDidier Lebrec
Sep 3, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Florence Wong, Francesco Salerno
Feb 16, 2012·The American Journal of Gastroenterology·Virginia Hernández-GeaCàndid Villanueva
Dec 25, 2012·Journal of Hepatology·Thomas ReibergerUNKNOWN Vienna Hepatic Hemodynamic Lab

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.